Current demand for plastics and chemical raw materials is met through large-scale production of ethylene from fossil fuels.

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from the destruction of insulin-producing β-cells in the ...

Infection rates from drug-resistant “nightmare bacteria” are on the rise in the U.S.—meaning that it is important to be aware of the risks, causes and how to slow the spread. The surge comes as part ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are ...

Mohammad Pourhosseinzadeh, M.D./Ph.D. student with Professor Mark Huising, watches undergraduate student Joel Sanchez working at a dissecting microscope. New work led by Pourhosseinzadeh and Huising ...

Jury selection has begun in the high-profile murder trial of Sarah Hartsfield, the Texas woman accused of killing her fifth husband with insulin. The proceedings mark the latest chapter in a case that ...

A new study from the CDC found that infection rates for a drug-resistant “nightmare bacteria” are on the rise, increasing nearly 70% between 2019 and 2023. The increase was primarily driven by the NDM ...